Lifecore Biomedical (NASDAQ:LFCR – Get Free Report) and ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.
Insider & Institutional Ownership
83.4% of Lifecore Biomedical shares are held by institutional investors. Comparatively, 76.0% of ANI Pharmaceuticals shares are held by institutional investors. 32.7% of Lifecore Biomedical shares are held by company insiders. Comparatively, 8.1% of ANI Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Profitability
This table compares Lifecore Biomedical and ANI Pharmaceuticals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Lifecore Biomedical | -29.93% | N/A | -16.16% |
| ANI Pharmaceuticals | 11.07% | 27.37% | 10.47% |
Risk & Volatility
Valuation and Earnings
This table compares Lifecore Biomedical and ANI Pharmaceuticals”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Lifecore Biomedical | $128.87 million | 1.20 | -$40.50 million | ($1.07) | -3.82 |
| ANI Pharmaceuticals | $883.37 million | 1.84 | $78.34 million | $4.64 | 15.24 |
ANI Pharmaceuticals has higher revenue and earnings than Lifecore Biomedical. Lifecore Biomedical is trading at a lower price-to-earnings ratio than ANI Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of current ratings and recommmendations for Lifecore Biomedical and ANI Pharmaceuticals, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Lifecore Biomedical | 1 | 1 | 1 | 0 | 2.00 |
| ANI Pharmaceuticals | 0 | 4 | 5 | 0 | 2.56 |
Lifecore Biomedical currently has a consensus target price of $6.50, suggesting a potential upside of 58.92%. ANI Pharmaceuticals has a consensus target price of $105.57, suggesting a potential upside of 49.32%. Given Lifecore Biomedical’s higher probable upside, research analysts plainly believe Lifecore Biomedical is more favorable than ANI Pharmaceuticals.
Summary
ANI Pharmaceuticals beats Lifecore Biomedical on 10 of the 14 factors compared between the two stocks.
About Lifecore Biomedical
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. The company engages in the manufacturing of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
About ANI Pharmaceuticals
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Receive News & Ratings for Lifecore Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lifecore Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
